STOK:NASDAQ, Stoke Therapeutics, Inc.

STOK stock overview

Stoke Therapeutics, Inc. (STOK:NASDAQ) closed at $27.21 on November 10, 2026, down 1.80% on the day. The stock trades 32.3% below its 52-week high of $40.22 and 24.8% above its 52-week low of $21.81. Over the past year, it gained 8.4%. Stoke Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $27.21
Day change: -1.80%
Volume: 838,276
Average volume: 1,057,493
Market cap: 1B+
52-week range: $21.81 – $40.22
50-day average: $26.75
200-day average: $30.84

Price action over the past year

In 252 trading sessions since November 10, 2025, STOK closed higher on 124 days (49%). Its best day was November 11, 2025 (+12.25%) and its worst was September 23, 2026 (-10.58%). The stock moved 10% or more in a single session 5 times.

Recent signals

Nov 10, 2026: Trading sideways between $26.07 and $27.71 over 14 days (Sideways scanner)
Oct 30, 2026: News catalyst: Biotech (News Catalysts scanner)

STOK news

Nov 7, 2026: Stoke Therapeutics (STOK) Faces A Valuation Test Following Weaker Nine Month Results
Nov 3, 2026: Stoke Therapeutics to Present at Upcoming Investor Conferences in November
Oct 31, 2026: Stoke Therapeutics (STOK) Stock Price Faces Q3 Results Cash Burn Question
Oct 30, 2026: Stoke (STOK) Q3 2026 Earnings Call Transcript
Oct 30, 2026: Stoke Therapeutics, Inc. Q3 2026 Earnings Call Summary
Oct 30, 2026: Stoke Therapeutics Misses On Launch-Driven Spending, But FDA Endpoint Deal Strengthens The Zorevunersen Case As Cash Runway Tightens
Oct 30, 2026: Stoke Therapeutics Q3 Earnings Call Highlights
Oct 29, 2026: Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates

About Stoke Therapeutics, Inc.

Stoke Therapeutics Inc is engaged in developing antisense oligonucleotide medicines. The medicine increases gene expression to treat genetic epilepsies and other severe monogenic diseases, including genetic conditions affecting the central nervous system, eye, liver and kidney.

Similar stocks

Find more stocks like STOK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.